This article discusses the use of beta-blockers by performing artists, the reasons why they are taken, and the potential associated risks. We argue that there are high levels of usage within sectors of the professional performing arts community and that there may be high levels of risk in using these medications, particularly without medical supervision. Previous studies have mentioned potential risks, but this article will be the first to analyse the potential negative impact of side effects from these medications upon specific aspects of instrumental playing.